In a surprise move yesterday the FDA put the brakes on a new drug that was supposed to take the place of EpiPen's to treat anaphylactic shock. And a nasty new virus is making the rounds in India.
Dr. David Pate, former CEO of St. Luke's Health System, joined Idaho Matters to talk more.